We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Precise glucose measurement in sodium fluoride-citrate plasma affects estimates of prevalence in diabetes and prediabetes.
- Authors
Heilmann, Geronimo; Trenkamp, Sandra; Möser, Clara; Bombrich, Maria; Schön, Martin; Yurchenko, Iryna; Strassburger, Klaus; Rodríguez, Marcos Matabuena; Zaharia, Oana-Patricia; Burkart, Volker; Wagner, Robert; Roden, Michael
- Abstract
Estimates of glucose concentrations vary among types of blood samples, which impact on the assessment of diabetes prevalence. Guidelines recommend a conversion factor to calculate plasma glucose from measurements of glucose in whole blood. The American Diabetes Association recommends the use of blood drawing tubes containing sodium fluoride (NaF) and citrate, which have not yet been evaluated regarding possible differences in glucose concentration and conversion factors. Thus, we compared glucose measurements in NaF-citrate plasma and venous whole blood and estimated the impact of differences on diabetes and prediabetes prevalence. Glucose differences were calculated by Bland-Altman analysis with pairwise comparison of glucose measurements from whole blood and NaF-citrate plasma (n=578) in clinical studies of the German Diabetes Center. Subsequently, we computed the impact of the glucose difference on diabetes and prediabetes prevalence in the population-based National Health and Nutrition Examination Survey (NHANES). Even upon conversion of whole blood to plasma glucose concentrations using the recommended conversion factor, mean glucose concentration difference remained 4.72 % higher in NaF-citrate plasma. Applying the higher glucose estimates, increases the population-based diabetes and prediabetes prevalence by 13.67 and 33.97 % or more than 7.2 and 13 million people in NHANES, respectively. Additional economic burden could be about 20 $ billion per year due to undiagnosed diabetes. The recommended conversion factor is not valid for NaF-citrate plasma. Systematic bias of glucose measurements due to sampling type leads to clinically relevant higher estimates of diabetes and prediabetes prevalence.
- Subjects
AMERICAN Diabetes Association; CITRATES; PREDIABETIC state; HEALTH &; Nutrition Examination Survey; GLUCOSE; BLOOD sugar
- Publication
Clinical Chemistry & Laboratory Medicine, 2024, Vol 62, Issue 4, p762
- ISSN
1434-6621
- Publication type
Article
- DOI
10.1515/cclm-2023-0770